SCHEMBL279655

SCHEMBL279655

CC(=O)c1ccccc1C(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
ALOX15 P16050 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 2/20 0.50
MAPT P10636 3/20 0.48
KMT2A Q03164 3/20 0.48
PBRM1 Q86U86 1/20 0.48
MEN1 O00255 1/20 0.48
NSD2 O96028 1/20 0.48
POLB P06746 1/20 0.48
MCL1 Q07820 1/20 0.48
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
BRD4 O60885 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11373632 0.97 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL7596837 0.97 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL9008317 0.97 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL1099217 0.91 ALDH1A1 (0.46) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL4975385 0.91 CES2 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL9520491 0.91 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
SCHEMBL286653 0.89 ALDH1A1 (0.74) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
Acetaldehyde SCHEMBL27408136 0.89 ALDH1A1 (0.44) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA
Benzene SCHEMBL11756425 0.89 ALDH1A1 (0.74) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL23391013 0.87 SMN1; SMN2 (0.42) ALDH1A1ALOX15SMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080343-A Method for synthesizing polyarylketone compound 2026-05-26 CN claimed
US-12465904-B2 Metal-organic frameworks having localized defects for gas separations ExxonMobil Technology and Engineering Company (US) 2025-11-11 US claimed
US-20250296071-A1 MIXED-METAL MIXED-ORGANIC FRAMEWORK SYSTEMS FOR SELECTIVE CO2 CAPTURE ExxonMobil Technology and Engineering Company 2025-09-25 US claimed
CN-119926191-B Conjugated microporous organic solvent-resistant nanofiltration composite membrane and preparation method and application thereof 中山大学 2025-06-13 CN claimed
CN-119926191-A Conjugated microporous organic solvent-resistant nanofiltration composite membrane and preparation method and application thereof 中山大学 2025-05-06 CN claimed
US-12121852-B2 Apparatus comprising a contaminant-resistant and non-corrosive desiccant composite with high moisture capacity W. L. GORE & ASSOCIATES, INC. (US) 2024-10-22 US claimed
CN-114173906-B Apparatus comprising a contaminant resistant and non-corrosive desiccant composite with high moisture capacity W.L.戈尔及同仁股份有限公司 2024-05-14 CN claimed
CN-117510369-A Photo-thermal double-effect high polymer initiator and preparation method and application thereof 中原工学院 2024-02-06 CN claimed
US-20240002417-A1 AQUEOUS-BASED SYNTHESIS OF METAL ORGANIC FRAMEWORKS ExxonMobil Technology and Engineering Company 2024-01-04 US claimed
US-20240001335-A1 HIGH SOLIDS CONCENTRATION SYNTHESIS OF METAL-ORGANIC FRAMEWORKS ExxonMobil Technology and Engineering Company 2024-01-04 US claimed
US-4921923-A Ethers of oligomeric phenol-diketone condensation products and a vinyl-benzyl compound ALLIED SIGNAL INC. (US) 1990-05-01 US claimed
EP-0215543-B1 A NEW PROCESS FOR MAKING POLYESTERS, POLYAMIDES AND POLYKETONES THE DOW CHEMICAL COMPANY (US) 1990-04-11 EP claimed
US-4762909-A Method for making polyketones THE DOW CHEMICAL COMPANY (US) 1988-08-09 US claimed
EP-0215543-A1 A new process for making polyesters, polyamides and polyketones THE DOW CHEMICAL COMPANY (US) 1987-03-25 EP claimed
US-4641059-A CHELATION OF ORGANOMETAL ACCELERATOR IN ADHESIVE RESINS; HIGH RESOLUTION SONY CORPORATION (JP) 1987-02-03 US claimed
US-4192958-A THERMOCRACKING HIGH-BOILING BY-PRODUCTS CONTAINED IN ACID-CLEAVAGE PRODUCT OF M-DIISOPROPYLBENZENE DIHYDROPEROXIDE, AROMATIC KETONE MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1980-03-11 US claimed
US-4162268-A BY OXIDATION OF DIETHYLBENZENE OR ETHYLACETOPHENONE; MANGANESE, COBALT, NICKEL, CHROMIUM, COPPER OR IRON SALT CATALYST ASAHI KASEI KOGYO K.K. (JP) 1979-07-24 US claimed
US-4120909-A DEHYDRATION OF METHYL PHENYL KETONES, CATALYST HERCULES INCORPORATED (US) 1978-10-17 US claimed
US-4036818-A Method of preparing polymers of polyphenylene type KORSHAK VASILY VLADIMIROVICH 1977-07-19 US claimed
US-3950431-A EXTRACTION WITH A SOLUTION OF AN ALCOHOL AND SODIUM HYDROXIDE OR SODIUM CARBONATE SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-04-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12465904-B2 Metal-organic frameworks having localized defects for gas separations EPCAM, CTCF, MDM4 ALDH1A1 2611/4885ALOX15 2516/4885SMN1; SMN2 4404/4885
US-20240001335-A1 HIGH SOLIDS CONCENTRATION SYNTHESIS OF METAL-ORGANIC FRAMEWORKS MDM4, OSTC, MCM4 ALDH1A1 4799/4885ALOX15 3835/4885SMN1; SMN2 2440/4885
US-20250296071-A1 MIXED-METAL MIXED-ORGANIC FRAMEWORK SYSTEMS FOR SELECTIVE CO2 CAPTURE CHRM4, CHRM1, EPCAM ALDH1A1 3068/4885ALOX15 3572/4885SMN1; SMN2 4425/4885
US-20240002417-A1 AQUEOUS-BASED SYNTHESIS OF METAL ORGANIC FRAMEWORKS MDM4, MYOF, MUS81 ALDH1A1 3164/4885ALOX15 2992/4885SMN1; SMN2 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.